Computer analyzes massive clinical databases to properly categorize asthma patients

March 18, 2014, Carnegie Mellon University

So many variables can contribute to shortness of breath that no person can keep them all straight. But a computer program, capable of tracking more than 100 clinical variables for almost 400 people, has shown it can identify various subtypes of asthma, which perhaps could lead to targeted, more effective treatments.

Wei Wu, a Carnegie Mellon University computational biologist who led the analysis of patient data from the federally funded Severe Asthma Research Program, said many of the patient clusters identified by the computational methods are consistent with subtypes already recognized by clinicians. Those include types of asthma related to allergies, sinus disease or environmental factors. But the analysis also identified clusters of that suggest new subtypes, including one in which frequent, severe appear to be associated with poor quality of life or depression in some obese women.

The findings by Wu and her collaborators, including physicians at nine major medical centers, have been published online by the Journal of Allergy and Clinical Immunology.

"The ultimate goal is to develop treatments that are based on the biological mechanisms underlying each cluster of patients, rather than simply treating the symptoms," said Wu, an associate research professor in Carnegie Mellon's Lane Center for Computational Biology. To that end, she and her collaborators now seek to analyze genetic and genomic factors associated with each of the patient clusters, which promises to identify specific targets for drug treatments.

To identify these patient clusters, Wu used machine learning algorithms, which are computational techniques that are capable of finding patterns in the data as well as learning from data and improving their performance with experience. The analysis was based on 112 variables, such as those measuring various lung functions, immune factors, family history, and medical history, for each of 378 people with and without asthma.

Other researchers have used statistical techniques to cluster asthma patients, but none has been able to account for as many variables for each patient as this new study.

"This approach has implications not just for asthma, but for all complex diseases, which include most chronic diseases," said lead co-author Dr. Sally E. Wenzel, director of the University of Pittsburgh Asthma Institute at UPMC and the University of Pittsburgh School of Medicine. Like asthma, such diseases as osteoporosis, Alzheimer's disease, kidney disease, Parkinson's disease and autoimmune diseases are caused by combinations of numerous genetic, environmental and lifestyle factors.

Wenzel said physicians might be able to integrate 10 clinical variables as they evaluate patients with complex diseases, but tracking 100 variables across a large patient population is a near-impossible task. Moreover, physicians have biases that can cloud their analyses.

"Only a few years ago, we were persuaded that medications worked for everyone and that the only reason people had severe symptoms was that they weren't taking their medications," Wenzel said. But that has proven not to be the case, as underscored in this latest analysis, which identified a cluster of patients who were heavily medicated with corticosteroids to reduce airway inflammation and who had biological evidence for using them, yet continued to suffer severe shortness of breath.

The study identified several patient clusters that correspond with clinically recognized patient subtypes, but it also identified a new group composed largely of female Hispanics who were obese and reported low quality of life. Though they had normal lung function with little inflammation, they suffered frequent and severe symptoms. Wu said more investigation is needed to identify what is causing asthma symptoms in this patient cluster. Conceivably, this finding could encourage doctors to screen some patients for depression, she added.

Many respond well to corticosteroids, but others likely need personalized treatment that targets specific genetic or genomic factors. For a complex disease such as , the gene expression studies necessary for pinpointing those targets are unlikely to be successful if patients aren't correctly categorized. Wu said computational techniques can play an important role in this initial step of identifying and grouping similar patients together.

Explore further: Severe asthma patients less responsive to treatment

Related Stories

Severe asthma patients less responsive to treatment

September 9, 2013
People with severe asthma, who are often described as 'steroid-dependent', are actually less likely to respond to the treatment they depend on, when compared to people with mild asthma.

New guidelines for severe asthma provide an updated definition of the disease and a new plan to tack

December 11, 2013
A new guideline has provided an updated definition of severe asthma along with new recommendations for treating the condition.

11 new genetic associations for asthma-with-hay fever

January 28, 2014
23andMe has participated in the first ever genome-wide association study of the combined asthma-with-hay fever phenotype. Led by researchers at the QIMR Berghofer Medical Research Institute, the study identified 11 independent ...

Which asthma drugs, dosages work best for African Americans?

February 19, 2014
The University of Illinois at Chicago has received funding from the National Institutes of Health to determine what combination and dosages of asthma medications works best to manage asthma in African Americans, who suffer ...

September peak month for kids' asthma flares, study finds

March 10, 2014
(HealthDay)— Many parents know that allergies are seasonal, but fewer may realize that the same is true of asthma: A new study suggests the riskiest time for children with asthma is September, as they head back to school.

Hope of new treatment for severe asthma patients

October 25, 2013
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.